| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.008 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |